Lactate dehydrogenase to albumin ratio (LAR) is a novel predictor of fatal outcome in patients with SFTS: an observational study

乳酸脱氢酶与白蛋白比值(LAR)是SFTS患者死亡结局的新型预测因子:一项观察性研究

阅读:1

Abstract

BACKGROUND: Severe fever with thrombocytopenia syndrome (SFTS) is a serious infectious disease. This study explored the prognostic value of lactate dehydrogenase (LDH) to albumin (ALB) ratio (LAR) levels in fatal outcomes of the disease. METHODS: Two-hundred and nine patients with SFTS were enrolled in this study. Based on the prognosis, patients were divided into survival and deceased groups. Laboratory metrics were compared by univariate Cox regression and multivariate Cox regression analyses. The prognostic risk factors for SFTS disease were discussed, and the receiver operator characteristic (ROC) curve and the Kaplan-Meier survival curve were plotted to analyze the predictive value of independent risk factors on disease prognosis. RESULTS: A total of 209 patients with SFTS, including 152 in the survival group and 57 in the death group, were enrolled. The median age of 209 SFTS patients was 64 years. Three indicators, age, aspartate aminotransferase (AST), and LAR, were identified as predictors of mortality in patients with SFTS. The area under the ROC curve of LAR was the highest (0.835), followed by that of AST (0.794), and age (0.720). The Kaplan-Meier survival curve showed an increased case fatality rate, of >1.4691, in patients with LAR. CONCLUSION: Elevated LAR level on admission is an independent risk factor for fatal outcomes in patients with SFTS; this can help healthcare professionals identify patients with SFTS having a high risk of fatal outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。